Combating Disease Through Innovative Therapies
Product PipelinePlatforms
DNase
Oncology platform aimed at improving immunotherapies by targeting Neutrophil Extracellular Traps (NETs)
Personalized CAR T platform targeting cancers with a patient- and tumor-specific approach.
XCART PlatformTransformative Technologies
Our proprietary and patented technologies are being utilized to create life-changing therapies.
Our Novel TechnologiesStock Information
Nasdaq: XBIO
Xenetic Biosciences, Inc.
Price
Change
Volume
Day Range
52 Week Range
